Collectively, these results support the conclusion that hUC‐MSCs treatment has effects on the conversion from proinflammatory to antiinflammatory profiles in SLE, probably caused by the reduction of HSP90AA1 in PI3K‐AKT signaling pathway induced by CD4+ T cell glucose metabolism activation. Here, HSP90AA1 is linked to systemic lupus erythematosus.